DK0443471T3 - 2-Deoxy-2-methylidencytidin-dihydrat, fremgangsmåder til fremstilling heraf, samt præparater - Google Patents

2-Deoxy-2-methylidencytidin-dihydrat, fremgangsmåder til fremstilling heraf, samt præparater

Info

Publication number
DK0443471T3
DK0443471T3 DK91102225.9T DK91102225T DK0443471T3 DK 0443471 T3 DK0443471 T3 DK 0443471T3 DK 91102225 T DK91102225 T DK 91102225T DK 0443471 T3 DK0443471 T3 DK 0443471T3
Authority
DK
Denmark
Prior art keywords
deoxy
preparations
processes
preparation
methylidenecytidine
Prior art date
Application number
DK91102225.9T
Other languages
English (en)
Inventor
Atsushi Sakai
Toshiyuki Shibata
Takayuki Ogawa
Shinji Sakata
Takanori Miyashita
Kazuhiko Kondo
Original Assignee
Yoshitomi Pharmaceutical
Yamasa Shoyu Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical, Yamasa Shoyu Kk filed Critical Yoshitomi Pharmaceutical
Application granted granted Critical
Publication of DK0443471T3 publication Critical patent/DK0443471T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK91102225.9T 1990-02-19 1991-02-16 2-Deoxy-2-methylidencytidin-dihydrat, fremgangsmåder til fremstilling heraf, samt præparater DK0443471T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2037695A JPH0615557B2 (ja) 1990-02-19 1990-02-19 2’―デオキシ―2’―メチリデンシチジンの2水和物結晶

Publications (1)

Publication Number Publication Date
DK0443471T3 true DK0443471T3 (da) 1995-06-26

Family

ID=12504690

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91102225.9T DK0443471T3 (da) 1990-02-19 1991-02-16 2-Deoxy-2-methylidencytidin-dihydrat, fremgangsmåder til fremstilling heraf, samt præparater

Country Status (9)

Country Link
US (2) US5183882A (da)
EP (1) EP0443471B1 (da)
JP (1) JPH0615557B2 (da)
KR (2) KR960010947B1 (da)
AT (1) ATE118012T1 (da)
CA (1) CA2036507C (da)
DE (1) DE69107098T2 (da)
DK (1) DK0443471T3 (da)
ES (1) ES2067780T3 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401726A (en) * 1988-08-25 1995-03-28 Yoshitomi Pharaceutical Industries, Ltd. 2'methylidenepyrimidine nucleoside compounds, their use and method for production thereof
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 2’―デオキシ―2’―メチリデンシチジンの2水和物結晶
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
BR9407300A (pt) * 1993-08-19 1996-10-08 Merck & Co Inc Composto cristalino de sal de ácido benzóico de 4'-deóxi-4'-epi-metilamino avermectina B1A/B1B hemiidratado processo para a sua preparação e para o controle de insetos agrícolas e composição útil para o tratamento de infestações de plantas ou de produtos de plantas
WO1995018815A1 (en) * 1994-01-07 1995-07-13 Merrell Pharmaceuticals Inc. Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
US5811408A (en) * 1994-07-12 1998-09-22 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides
US5665711A (en) * 1995-12-12 1997-09-09 Yoshitomi Pharmaceutical Industries, Ltd. Antitumor composition for oral administration
EP2106788A1 (en) * 2008-04-04 2009-10-07 Ipsen Pharma Liquid and freeze dried formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007049A1 (fr) * 1987-03-19 1988-09-22 Yamasa Shoyu Kabushiki Kaisha Derives de nucleosides de 2'-alkylidene pyrimidine, procede de preparation et utilisation de ces composes
JPS63258818A (ja) * 1987-04-16 1988-10-26 Yoshitomi Pharmaceut Ind Ltd 制ガン剤
ATE123289T1 (de) * 1988-12-07 1995-06-15 Yamasa Shoyu Kk Verbindungen von pyrimidin 2'-methylidin nukleosiden.
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 2’―デオキシ―2’―メチリデンシチジンの2水和物結晶

Also Published As

Publication number Publication date
ATE118012T1 (de) 1995-02-15
EP0443471B1 (en) 1995-02-01
KR960010947B1 (ko) 1996-08-14
KR0174212B1 (ko) 1999-02-01
EP0443471A1 (en) 1991-08-28
US5183882A (en) 1993-02-02
CA2036507A1 (en) 1991-08-20
DE69107098T2 (de) 1995-06-29
JPH0615557B2 (ja) 1994-03-02
ES2067780T3 (es) 1995-04-01
DE69107098D1 (de) 1995-03-16
JPH03240794A (ja) 1991-10-28
KR970005016A (ko) 1997-01-29
CA2036507C (en) 1996-09-10
KR910021351A (ko) 1991-12-20
US5412089A (en) 1995-05-02

Similar Documents

Publication Publication Date Title
DK502888A (da) Anvendelse af azithromycin og derivater deraf til fremstilling af antiprotozoale laegemidler
FI883596A7 (fi) Epipodofyllotoxinglukosid-4' -fosfatderivat.
DZ1270A1 (fr) Dérivés de fluorocytidine.
DE3853922D1 (de) Aminosäurederivate als Amphotere.
DK172089D0 (da) 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf
OA06063A (fr) Dérivés de l'anthelmintique C-076.
DK631688D0 (da) 2',3'-dideoxy-2'-fluornucleosider, fremstillingen deraf samt praeparater indeholdende samme
DE3776261D1 (de) Naehrstoffzusammensetzung.
DK0443471T3 (da) 2-Deoxy-2-methylidencytidin-dihydrat, fremgangsmåder til fremstilling heraf, samt præparater
ZA892284B (en) Novel fluorophosphonate nucleotide derivatives
NO882849D0 (no) 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
DK218388A (da) Aktivt princip isoleret fra hajvaev
FR2653771B1 (fr) Procede de preparation de l'azt (azido-3'-desoxy-3'-thymidine) et de composes apparentes.
DE3783937D1 (de) 1,4-naphthochinonderivate enthaltende rodentizide zusammensetzungen.
DE3789032D1 (de) Mechanismus zur Einstellung eines Ausgangsgliedes.
OA06102A (fr) Compositions à base de dérivés d'acides - isocyanocarboxyliques, destinées à influencer la croissance des végétaux.
DE3881406D1 (de) Cycloalkan(1,2-c:4,3-c')dipyrazole.
DE3880088D1 (de) Ethylierte avermectine.
SE7701506L (sv) Antihypertensiva medel
OA09221A (fr) "Synthèse asymétrique des dérivés de la furo (3, 4-c) pyridine".
ES2004489A4 (es) Gametocidas de piridina.
ZA909161B (en) Glutaric acid derivatives and preparations thereof
FI880081A7 (fi) 2,1-bensotiazepin-2,2-dioxid-5 -karboxylsyraderivat.
DK161888D0 (da) Trioxabicyclo (2.2.2) octanderivater
ES551865A0 (es) Procedimiento para la preparacion de derivados de 5'-o-(glicosilureidosulfonil) uridina.